PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1625252
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1625252
Biophotonics Market Forecasts to 2030 - Global Analysis By Technology (In-vivo and In-vitro), Application, End User and By Geography
According to Stratistics MRC, the Global Biophotonics Market is accounted for $76.08 billion in 2024 and is expected to reach $151.79 billion by 2030 growing at a CAGR of 12.2% during the forecast period. Biophotonics is the study and application of light-based technologies in biological and medical sciences. It involves using light to understand and manipulate biological systems, such as cells, tissues, and organs. This interdisciplinary field combines principles from physics, biology, and engineering to develop tools for imaging, diagnosis, therapy, and treatment. Techniques like fluorescence microscopy, optical coherence tomography, and laser-based therapies are common in biophotonics, enabling advancements in areas such as medical imaging, disease detection, and targeted treatments.
Market Dynamics:
Driver:
Government support and funding
Financial backing from government agencies often accelerates the development of new biophotonic technologies, enabling breakthroughs in medical diagnostics, imaging, and therapy. Grants, subsidies, and tax incentives encourage private companies to invest in biophotonics, reducing the financial risks associated with developing novel technologies. Additionally, public funding supports collaborations between universities, research institutions, and industry leaders, facilitating the commercialization of biophotonic products. Government initiatives aimed at advancing healthcare and medical devices further drive demand for biophotonic applications in clinical and laboratory settings. This collective support not only stimulates market growth but also ensures the integration of cutting-edge technologies into mainstream healthcare solutions.
Restraint:
Technical limitations
Complexities in integrating photonics with biological systems create challenges in precision and reliability. High costs associated with advanced biophotonics technologies restrict their widespread adoption in research and clinical applications. The lack of standardization and interoperability between devices hampers seamless integration into existing healthcare infrastructures. Additionally, limitations in the sensitivity and resolution of imaging systems prevent accurate diagnostics and therapeutic monitoring. Finally, the need for specialized training and expertise to operate biophotonics tools adds another barrier to widespread implementation.
Opportunity:
Expanding applications in regenerative medicine
The use of light-based technologies in tissue regeneration, such as laser-based therapies and imaging techniques, is enhancing the precision and effectiveness of medical treatments. Biophotonics enables better visualization and monitoring of cellular processes, which is critical in developing new regenerative therapies. With advances in stem cell research and gene therapy, biophotonics tools are essential for tracking cellular behavior and tissue regeneration. The demand for non-invasive diagnostic tools also contributes to the growth of biophotonics in regenerative medicine. As regenerative medicine continues to evolve, biophotonics plays a crucial role in enabling groundbreaking therapies and improving patient outcomes.
Threat:
Privacy and data security concerns
The sensitive nature of medical data generated through biophotonics applications raises fears of unauthorized access and misuse. Stringent regulations, such as GDPR, require biophotonics companies to invest heavily in secure systems, adding to operational costs. Inadequate data protection measures can lead to potential breaches, harming a company's reputation and credibility. Consumer reluctance to share personal health information further slows adoption of biophotonics technologies. Consequently, these concerns delay the widespread implementation of innovative biophotonics solutions in medical diagnostics and treatment.
Covid-19 Impact
The Covid-19 pandemic significantly impacted the biophotonics market, with disruptions in manufacturing, supply chains, and research activities. However, it also accelerated the adoption of biophotonics in healthcare, particularly for diagnostic and therapeutic applications. Increased demand for rapid, non-invasive testing, such as for Covid-19 detection and monitoring, drove innovations in optical biosensors and imaging systems. Despite initial setbacks, the pandemic highlighted the importance of biophotonics in medical diagnostics, boosting long-term growth prospects in the sector as investment in healthcare technologies increased globally.
The in-vivo segment is expected to be the largest during the forecast period
The in-vivo segment is estimated to have a lucrative growth, by enabling real-time imaging and monitoring of biological processes. It allows for non-invasive, high-resolution visualization of tissues, cells, and organs, enhancing diagnostic accuracy and treatment monitoring. The growing demand for personalized medicine and early disease detection further fuels the adoption of in-vivo biophotonics. Additionally, its applications in drug discovery and pre-clinical studies drive market growth by improving the efficiency and success rates of pharmaceutical developments. With increasing research investments and healthcare advancements, the in-vivo segment continues to shape the future of the Biophotonics market.
The medical therapeutic segment is expected to have the highest CAGR during the forecast period
The medical therapeutic segment is anticipated to witness the highest CAGR growth during the forecast period, due to advanced diagnostic and treatment methods. It facilitates non-invasive imaging techniques, such as optical coherence tomography (OCT), which enhances disease detection and monitoring. Biophotonics also supports targeted therapies, improving the precision of treatments for conditions like cancer. Additionally, innovations in laser technologies allow for more effective surgeries with faster recovery times. As healthcare demands evolve, the medical sector's reliance on biophotonics for improved patient care continues to expand, stimulating market growth.
Region with largest share:
Asia Pacific is expected to hold the largest market share during the forecast period by advancements in healthcare, agriculture, and environmental sectors. Increasing demand for diagnostic technologies, such as imaging and spectroscopy, coupled with the rising prevalence of chronic diseases, is propelling the market. The region's booming biotechnology and medical device industries further contribute to the demand for biophotonics. Countries like China, Japan, and India are at the forefront, with substantial investments in research and development, fostering innovation in therapeutic and diagnostic applications.
Region with highest CAGR:
North America is expected to have the highest CAGR over the forecast period, owing to advancements in medical diagnostics, therapeutics, and research applications. Key technologies include optical coherence tomography (OCT), fluorescence imaging, and Raman spectroscopy, widely used in cancer detection, drug delivery, and tissue analysis. The region benefits from a robust healthcare infrastructure, substantial investments in research and development, and a high demand for non-invasive diagnostic techniques. Leading players in the U.S. and Canada are investing in innovative solutions, fostering growth. Government initiatives, coupled with increasing healthcare awareness, further support the market's expansion in North America.
Key players in the market
Some of the key players profiled in the Biophotonics Market include Thermo Fisher Scientific Inc., Carl Zeiss AG, Horiba Ltd., Olympus Corporation, Abcam Plc, Biolitec AG, Agilent Technologies Inc., Sartorius AG, Lumenis Ltd., PerkinElmer Inc. and LightLab Imaging, Inc.
Key Developments:
In November 2024, Carl Zeiss Meditec AG entered a strategic partnership with the Singapore Eye Research Institute (SERI). This collaboration focuses on improving surgical outcomes in refractive and cataract surgeries, with a funding commitment under Singapore's Research, Innovation and Enterprise.
In January 2024, Thermo Fisher announced a strategic collaboration with Galapagos NV for decentralized CAR-T manufacturing in the San Francisco area. This agreement includes providing GMP manufacturing and logistics services for Galapagos' CAR-T clinical program, marking a significant step in expanding their decentralized manufacturing strategy.
In July 2023, Carl Zeiss entered a long-term strategic partnership with the European Molecular Biology Laboratory (EMBL). This collaboration is focused on advancing research in molecular biology through innovative imaging technologies.
Technologies Covered:
- In-vivo
- In-vitro
Applications Covered:
- See-through Imaging
- Inside Imaging
- Spectro Molecular
- Surface Imaging
- Microscopy
- Light Therapy
- Analytical Sensing
- Biosensors
- Other Applications
End Users Covered:
- Medical Diagnostics
- Medical Therapeutic
- Tests & Components
- Nonmedical Application
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Technology Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Biophotonics Market, By Technology
- 5.1 Introduction
- 5.2 In-vivo
- 5.3 In-vitro
6 Global Biophotonics Market, By Application
- 6.1 Introduction
- 6.2 See-through Imaging
- 6.3 Inside Imaging
- 6.4 Spectro Molecular
- 6.5 Surface Imaging
- 6.6 Microscopy
- 6.6 Light Therapy
- 6.8 Analytical Sensing
- 6.9 Biosensors
- 6.10 Other Applications
7 Global Biophotonics Market, By End User
- 7.1 Introduction
- 7.2 Medical Diagnostics
- 7.3 Medical Therapeutic
- 7.4 Tests & Components
- 7.5 Nonmedical Application
- 7.6 Other End Users
8 Global Biophotonics Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Thermo Fisher Scientific Inc.
- 10.2 Carl Zeiss AG
- 10.3 Horiba Ltd.
- 10.4 Olympus Corporation
- 10.5 Abcam Plc
- 10.6 Biolitec AG
- 10.7 Agilent Technologies Inc.
- 10.8 Sartorius AG
- 10.9 Lumenis Ltd.
- 10.10 PerkinElmer Inc.
- 10.11 LightLab Imaging, Inc.
- 10.12 Medtronic Plc
- 10.13 Photonis Technologies
- 10.14 Nikon Corporation
- 10.15 Beckman Coulter, Inc.
List of Tables
- Table 1 Global Biophotonics Market Outlook, By Region (2022-2030) ($MN)
- Table 2 Global Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
- Table 3 Global Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
- Table 4 Global Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
- Table 5 Global Biophotonics Market Outlook, By Application (2022-2030) ($MN)
- Table 6 Global Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
- Table 7 Global Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
- Table 8 Global Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
- Table 9 Global Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
- Table 10 Global Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
- Table 11 Global Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
- Table 12 Global Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
- Table 13 Global Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
- Table 14 Global Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
- Table 15 Global Biophotonics Market Outlook, By End User (2022-2030) ($MN)
- Table 16 Global Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
- Table 17 Global Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
- Table 18 Global Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
- Table 19 Global Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
- Table 20 Global Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 21 North America Biophotonics Market Outlook, By Country (2022-2030) ($MN)
- Table 22 North America Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
- Table 23 North America Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
- Table 24 North America Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
- Table 25 North America Biophotonics Market Outlook, By Application (2022-2030) ($MN)
- Table 26 North America Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
- Table 27 North America Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
- Table 28 North America Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
- Table 29 North America Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
- Table 30 North America Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
- Table 31 North America Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
- Table 32 North America Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
- Table 33 North America Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
- Table 34 North America Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
- Table 35 North America Biophotonics Market Outlook, By End User (2022-2030) ($MN)
- Table 36 North America Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
- Table 37 North America Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
- Table 38 North America Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
- Table 39 North America Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
- Table 40 North America Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 41 Europe Biophotonics Market Outlook, By Country (2022-2030) ($MN)
- Table 42 Europe Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
- Table 43 Europe Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
- Table 44 Europe Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
- Table 45 Europe Biophotonics Market Outlook, By Application (2022-2030) ($MN)
- Table 46 Europe Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
- Table 47 Europe Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
- Table 48 Europe Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
- Table 49 Europe Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
- Table 50 Europe Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
- Table 51 Europe Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
- Table 52 Europe Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
- Table 53 Europe Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
- Table 54 Europe Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
- Table 55 Europe Biophotonics Market Outlook, By End User (2022-2030) ($MN)
- Table 56 Europe Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
- Table 57 Europe Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
- Table 58 Europe Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
- Table 59 Europe Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
- Table 60 Europe Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 61 Asia Pacific Biophotonics Market Outlook, By Country (2022-2030) ($MN)
- Table 62 Asia Pacific Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
- Table 63 Asia Pacific Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
- Table 64 Asia Pacific Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
- Table 65 Asia Pacific Biophotonics Market Outlook, By Application (2022-2030) ($MN)
- Table 66 Asia Pacific Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
- Table 67 Asia Pacific Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
- Table 68 Asia Pacific Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
- Table 69 Asia Pacific Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
- Table 70 Asia Pacific Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
- Table 71 Asia Pacific Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
- Table 72 Asia Pacific Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
- Table 73 Asia Pacific Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
- Table 74 Asia Pacific Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
- Table 75 Asia Pacific Biophotonics Market Outlook, By End User (2022-2030) ($MN)
- Table 76 Asia Pacific Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
- Table 77 Asia Pacific Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
- Table 78 Asia Pacific Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
- Table 79 Asia Pacific Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
- Table 80 Asia Pacific Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 81 South America Biophotonics Market Outlook, By Country (2022-2030) ($MN)
- Table 82 South America Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
- Table 83 South America Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
- Table 84 South America Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
- Table 85 South America Biophotonics Market Outlook, By Application (2022-2030) ($MN)
- Table 86 South America Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
- Table 87 South America Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
- Table 88 South America Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
- Table 89 South America Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
- Table 90 South America Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
- Table 91 South America Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
- Table 92 South America Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
- Table 93 South America Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
- Table 94 South America Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
- Table 95 South America Biophotonics Market Outlook, By End User (2022-2030) ($MN)
- Table 96 South America Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
- Table 97 South America Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
- Table 98 South America Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
- Table 99 South America Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
- Table 100 South America Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 101 Middle East & Africa Biophotonics Market Outlook, By Country (2022-2030) ($MN)
- Table 102 Middle East & Africa Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
- Table 103 Middle East & Africa Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
- Table 104 Middle East & Africa Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
- Table 105 Middle East & Africa Biophotonics Market Outlook, By Application (2022-2030) ($MN)
- Table 106 Middle East & Africa Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
- Table 107 Middle East & Africa Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
- Table 108 Middle East & Africa Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
- Table 109 Middle East & Africa Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
- Table 110 Middle East & Africa Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
- Table 111 Middle East & Africa Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
- Table 112 Middle East & Africa Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
- Table 113 Middle East & Africa Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
- Table 114 Middle East & Africa Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
- Table 115 Middle East & Africa Biophotonics Market Outlook, By End User (2022-2030) ($MN)
- Table 116 Middle East & Africa Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
- Table 117 Middle East & Africa Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
- Table 118 Middle East & Africa Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
- Table 119 Middle East & Africa Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
- Table 120 Middle East & Africa Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
